Sfoglia per Autore
In vitro characterization of tripitramine, a polymethylene tetraamine displaying high selectivity and affinity for muscarinic M2 receptors
1995 Chiarini A.; Budriesi R.; Bolognesi M.L.; Minarini A.; Melchiorre C.
Pyrrolo[2,1-c][1,4]benzothiazines: Synthesis, Structure-Activity Relationships, Molecular Modeling Studies, and Cardiovascular Activity
1995 Campiani G.; Garofalo A.; Fiorini I.; Botta M.; Nacci V.; Tafi A.; Chiarini A.; Budriesi R.; Bruni G.; Romeo M.R.
Synthesis and pharmacological characterization of some benzazepinone derivatives
1995 Budriesi R.; Rampa A.; Bisi A.; Fabbri G.; Chiarini A.; Valenti P.
1,4-Dihydropyridines containing R-NNO-azoxy moieties
1995 Gasco A.M.; Ermondi G.; Gasco A.; Budriesi R.; Chiarini A.
Synthesis, muscarinic blocking activity and molecular modeling studies of 4-DAMP-related compounds
1995 Recanatini M.; Tumiatti V.; Budriesi R.; Chiarini A.; Sabatino P.; Bolognesi M.L.; Melchiorre C.
Structure-activity relationship studies of xanthone and fluorenone-1,4-dihydropyridine-5-phosphonates
1996 Budriesi R.; Rampa A.; Bisi A.; Fabbri G.; Chiarini A.; Valenti P.
Synthesis and pharmacological profile of some chloroxanthone-1,4-dihydropyridine derivatives
1996 Bisi A.; Budriesi R.; Rampa A.; Fabbri G.; Chiarini A.; Valenti P.
Tetraamines as lead compounds for the design of neurotransmitter receptor ligands:Focus on α-adrenergic and muscarinic receptors recognition
1996 Melchiorre C.; Angeli P.; Bolognesi M.L.; Budriesi R.; Cacciaguerra S.; Chiarini A.; Crucianelli M.; Giardina D.; Gulini U.; Marucci G.; Minarini A.; Spampinato S.; Tumiatti V.
Synthesis and biological profile at muscarinic M2 and M3 receptor subtypes of some analogs of diphenidol
1996 Varoli L.; Burnelli S.; Budriesi R.; Guarnieri A.; Chiarini A.; Recanatini M.
Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): From dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers
1996 Campiani G.; Fiorini I.; De Filippis M.P.; Ciani S.M.; Garofalo A.; Nacci V.; Giorgi G.; Sega A.; Botta M.; Chiarini A.; Budriesi R.; Bruni G.; Romeo M.R.; Manzoni C.; Mennini T.
1,4-Dihydropyridine bearing a pharmacophoric fragment of lidoflazine
1996 Chiarini A.; Rampa A.; Budriesi R.; Bisi A.; Fabbri G.; Valenti P.
Universal template approach to drug design: Polyamines as selective muscarinic receptor antagonists
1998 Bolognesi M.L.; Minarini A.; Budriesi R.; Cacciaguerra S.; Chiarini A.; Spampinato S.; Tumiatti V.; Melchiorre C.
Coumarin 1,4-dihydropyridine derivatives
1998 Valenti P.; Rampa A.; Budriesi R.; Bisi A.; Chiarini A.
Search for selective antagonists at α1-adrenoreceptors: Neutral or negative antagonism?
1998 Melchiorre C.; Bolognesi M.L.; Budriesi R.; Chiarini A.; Giardina D.; Minarini A.; Quaglia W.; Leonardi A.
Search for α1-adrenoceptor subtypes selective antagonists: Design, synthesis and biological activity of cystazosin, an α(1D)-adrenoceptor antagonist
1998 Minarini A.; Budriesi R.; Chiarini A.; Leonardi A.; Melchiorre C.
Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for α1-adrenoreceptor subtypes
1998 Bolognesi M.L.; Budriesi R.; Chiarini A.; Poggesi E.; Leonardi A.; Melchiorre C.
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for α1-adrenoreceptor subtypes and 5-HT(1A) receptors
1999 Bolognesi M.L.; Budriesi R.; Cavalli A.; Chiarini A.; Gotti R.; Leonardi A.; Minarini A.; Poggesi E.; Recanatini M.; Rosini M.; Tumiatti V.; Melchiorre C.
Design, synthesis, and in vitro activity of catamphiphilic reverters of multidrug resistance: Discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar range
1999 Teodori E.; Dei S.; Quidu P.; Budriesi R.; Chiarini A.; Garnier-Suillerot A.; Gualtieri F.; Manetti D.; Romanelli M.N.; Scapecchi S.
Design, synthesis, and biological evaluation of symmetrically and unsymmetrically substituted methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists
1999 Rosini M.; Budriesi R.; Bixel M.G.; Bolognesi M.L.; Chiarini A.; Hucho F.; Krogsgaard-Larsen P.; Mellor I.R.; Minarini A.; Tumiatti V.; Usherwood P.N.R.; Melchiorre C.
Structure-activity relationship studies on the potent multidrug resistance (MDR) modulator 2-(3,4-dimethoxyphenyl)-2-(methylethyl)-5[(anthr-9-yl) methylamino]pentanenitrile (MM 36)
2001 Teodori E.; Dei S.; Garnier-Suillerot A.; Quidu P.; Scapecchi S.; Budriesi R.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile